SWOG clinical trial number
S9705

Phase II Trial of Cisplatin, Etoposide and Paclitaxel (Taxol®) With G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Phase II Trial of Cisplatin, Etoposide and Paclitaxel (Taxol®) With G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer
Activated
08/15/1997
Closed
07/01/1998

Research committees

Lung Cancer

Publication Information Expand/Collapse

2001

Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group 1,2

K Kelly;PA Bunn;L Lovato;J Crowley;RB Livingston;DR Gandara Clinical Cancer Research 7:2325-2329

2000

Final results from Southwest Oncology Group trial (SWOG) 9705: A phase II trial of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients (PTS) with extensive small cell lung (SCLC).

K Kelly;PA Bunn;L Lovato;J Crowley;RB Livingston;DR Gandara Proc of the American Society of Clinical Oncology 19:492a(#1923)

A phase II study of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients with extensive small cell lung cancer: a Southwest Oncology Group trial.

K Kelly;PA Bunn;L Lovato;J Crowley;RB Livingston;DR Gandara Lung Cancer 29(Suppl.2):8(#20)

1999

Preliminary toxicity results from Southwest Oncology Group trial (SWOG) 9705: A phase II trial of cisplatin, etoposide and paclitaxel (PET) with G-CSF in untreated patients (PTS) with extensive small cell lung cancer (SCLC).

PA Bunn;K Kelly;J Crowley;RB Livingston;DR Gandara Proc of the American Society of Clinical Oncology 18:468a(#1807)

Other Clinical Trials

SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open